| 英文别名 |
4-Ethyl-N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)-3-(pyrazolo[1,5-a]pyrimidin-6-ylethynyl)benzamide;4-Ethyl-N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)-phenyl)-3-(pyrazolo[1,5-a]pyrimidin-6-ylethynyl)benzamide;7rh;DDR1-IN-2;4-ethyl-N-{3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl}-3-(2-{pyrazolo[1,5-a]pyrimidin-6-yl}ethynyl)benzamide;4-Ethyl-N-{3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl-3-(2-{pyrazolo[1,5-a]pyrimidin-6-ylethynyl)benzamide;BDBM50430839;AKOS027427003;NCGC00347217-03;4-Ethyl-n-(3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl)-3-(2-(pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamide;P16587;CS-0035397;4-ethyl-N-(3-(trifluoromethyl)-5-((4-methylpiperazin-1-yl)methyl)phenyl)-3-(2-(pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamide;SCHEMBL19801991;HY-U00444;DDR1-IN-7rh;DDR1 inhibitor 7rh;DDLPXZXBWGJRGK-UHFFFAOYSA-N;GLXC-10931;AS-53501;SB19063;1429617-90-2;NCGC00347217-01;BR162591;CHEMBL2336015;DDR1 Inhibitor 7rh, >=98% (HPLC);C30H29F3N6O;PRP003-013;4-ethyl-N-[3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-3-(2-pyrazolo[1,5-a]pyrimidin-6-ylethynyl)benzamide;MFCD30185014;DA-52374 |